Fundings for medical technology in February 2014 totaled $537 million, buoyed by the $104.7 million funding of HeartFlow, Inc.. Below is a list of the month’s top fundings:
|HeartFlow, Inc., has raised $104.7 million in a round of funding according to a regulatory filing||Fractional flow reserve measurement for assessment of coronary artery disease|
|Paradigm Spine has established a $75 million credit facility with PDL BioPharma according to press reports||Minimally invasive treatments for spinal stenosis|
|GC Aesthetics has raised $60 million in a round of funding according to the company||Breast implants and other products in aesthetics|
|Direct Flow Medical, Inc., has raised $50 million in a debt funding according to press reports||Aortic valve implant for treatment of mitral valve regurgitation|
|Seno Medical Instruments, Inc., has raised $34.6 million of a planned $39 million Series C round of funding according to press reports||Opto-acoustic imaging for diagnostics, initially targeted as an adjunct to mammography|
|Alimera Sciences, Inc., has raised $37.5 million in funding according to the company||Ophthalmic drug-device technology|
|Cheetah Medical Ltd has raised $28.85 million according to a regulatory filing||Continuous, non-invasive cardiac output and hemodynamic monitoring based on “bioreactance” technology|
For the complete list of medtech fundings during February 2014, see link.
For a full list of the fundings in medtech since 2009, see link.